main-logo

ICD-10 Code D29.1 | Benign neoplasm of prostate Symptoms, Diagnosis, Billing

Benign neoplasm of the prostate, classified under ICD-10 code D29.1, refers to a non-cancerous tumor that arises from the prostate gland. This condition is significant as it can lead to urinary symptoms and complications if left untreated. Accurate coding with D29.1 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code D29.1 for Benign neoplasm of prostate?

ICD-10 Code D29.1 represents a benign neoplasm of the prostate, which is a non-malignant growth that can cause urinary obstruction and other symptoms. This code should be used in clinical documentation when a patient is diagnosed with this condition, ensuring accurate billing and facilitating appropriate treatment plans.

ICD-10 Code D29.1 – Clinical Definition and Explanation of Benign neoplasm of prostate

Benign neoplasms of the prostate are typically caused by hyperplastic changes in the prostate tissue, leading to the formation of non-cancerous tumors. These growths can progress slowly and may require medical intervention if they cause significant urinary symptoms or complications. Prompt diagnosis and management are crucial to prevent further complications.

Key Clinical Features:

  • Urinary frequency and urgency
  • Difficulty starting or stopping urination
  • Weak or interrupted urine flow
  • Possible pelvic discomfort or pain

ICD-10 Code D29.1 for Benign neoplasm of prostate – SOAP Notes & Clinical Use

ICD-10 Code D29.1 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to benign neoplasm of the prostate. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation and continuity of care.

What Does ICD-10 Code D29.1 for Benign neoplasm of prostate Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D29.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of benign neoplasm of the prostate. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D29.1 – Benign neoplasm of prostate

Management of benign neoplasm of the prostate may require hospitalization if complications arise. Treatment options focus on symptom relief and may include surgical intervention if necessary.

Antibiotic Therapy:

  • Not applicable as this is not an infectious condition

Supportive Care:

  • Alpha-blockers to relieve urinary symptoms
  • 5-alpha-reductase inhibitors to reduce prostate size
  • Regular monitoring of urinary function
  • Patient education on lifestyle modifications

Infection Control:

  • Not applicable as this is not an infectious condition

How to Document Symptoms of Benign neoplasm of prostate (ICD-10 D29.1) in SOAP Notes

Subjective:

  • Patient reports increased urinary frequency
  • Complaints of weak urine stream
  • Experiences urgency and nocturia
  • Denies hematuria or severe pain

Objective:

  • Prostate examination reveals enlargement
  • Urinalysis shows no signs of infection
  • Post-void residual volume is elevated
  • Vital signs within normal limits
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Benign neoplasm of prostate (ICD-10 Code D29.1)

Assessment:

  • Diagnosis: Benign neoplasm of prostate, moderate severity
  • ICD-10 Code: D29.1
  • Contributing factors: Age-related hyperplasia
  • No evidence of malignancy noted

Plan:

  • Initiate treatment with alpha-blockers
  • Schedule follow-up in 6 months
  • Educate patient on symptom management
  • Consider referral to urology if symptoms worsen

Treatment & Plan Section for ICD-10 Code D29.1 – Benign neoplasm of prostate

  • First-line treatment includes alpha-blockers for symptom relief
  • Consider 5-alpha-reductase inhibitors for prostate size reduction
  • Monitor urinary symptoms and prostate size regularly
  • Educate patients on lifestyle changes to alleviate symptoms

Using ICD-10 Code D29.1 for Benign neoplasm of prostate in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and findings under Subjective (S) and Objective (O)
  • Use D29.1 for billing when benign neoplasm is confirmed
  • Align treatment plans with clinical guidelines to support justified billing
  • Include relevant CPT codes that correspond to the services provided

ICD-10 Code D29.1 in Medical Billing and Insurance for Benign neoplasm of prostate

ICD-10 Code D29.1 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate reimbursement for services related to benign neoplasm of the prostate.

Billing Notes:

  • Document all relevant patient history and symptoms clearly
  • Use D29.1 in conjunction with appropriate CPT codes for billing
  • Ensure compliance with payer guidelines for coding and documentation
  • Review coding updates regularly to maintain accuracy

Common CPT Pairings:

CPT CodeDescription
52000Cystoscopy, diagnostic, including collection of specimen(s) by brushing or washing, when performed
52400Transurethral resection of prostate (TURP)
51798Measurement of post-voiding residual urine and/or bladder capacity by ultrasound
99213Established patient office visit, Level 3

Frequently Asked Questions

Common Questions About Using ICD-10 Code D29.1 for Benign neoplasm of prostate

What are the common symptoms of benign neoplasm of the prostate?

Common symptoms include increased urinary frequency, urgency, weak urine stream, and nocturia. Patients may also experience pelvic discomfort. These symptoms can significantly impact quality of life.

How is benign neoplasm of the prostate diagnosed?

Diagnosis typically involves a physical examination, digital rectal exam (DRE), and imaging studies. Urinalysis may be performed to rule out infection or other conditions.

What treatment options are available for benign neoplasm of the prostate?

Treatment options include medications such as alpha-blockers and 5-alpha-reductase inhibitors. Surgical options may be considered if symptoms are severe or unresponsive to medical therapy.

Is benign neoplasm of the prostate a serious condition?

While benign neoplasms are non-cancerous, they can lead to significant urinary symptoms and complications if not managed appropriately. Regular monitoring and treatment are essential.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved